These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15276404)

  • 1. Arsenic toxicity at low doses: epidemiological and mode of action considerations.
    Schoen A; Beck B; Sharma R; Dubé E
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):253-67. PubMed ID: 15276404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
    Snow ET; Sykora P; Durham TR; Klein CB
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):557-64. PubMed ID: 15996700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seafood arsenic: implications for human risk assessment.
    Borak J; Hosgood HD
    Regul Toxicol Pharmacol; 2007 Mar; 47(2):204-12. PubMed ID: 17092619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure.
    Liao CM; Shen HH; Chen CL; Hsu LI; Lin TL; Chen SC; Chen CJ
    J Hazard Mater; 2009 Jun; 165(1-3):652-63. PubMed ID: 19062162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
    Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
    Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
    Kitchin KT; Conolly R
    Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health effect levels for risk assessment of childhood exposure to arsenic.
    Tsuji JS; Benson R; Schoof RA; Hook GC
    Regul Toxicol Pharmacol; 2004 Apr; 39(2):99-110. PubMed ID: 15041143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects.
    Schuhmacher-Wolz U; Dieter HH; Klein D; Schneider K
    Crit Rev Toxicol; 2009; 39(4):271-98. PubMed ID: 19235533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
    Kitchin KT
    Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
    Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
    Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview on chronic arsenism via drinking water in PR China.
    Xia Y; Liu J
    Toxicology; 2004 May; 198(1-3):25-9. PubMed ID: 15138026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review.
    Yoshida T; Yamauchi H; Fan Sun G
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):243-52. PubMed ID: 15276403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water intake in an Asian population living in arsenic-contaminated area.
    Watanabe C; Kawata A; Sudo N; Sekiyama M; Inaoka T; Bae M; Ohtsuka R
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):272-82. PubMed ID: 15276406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water consumption patterns in rural Bangladesh: are we underestimating total arsenic load?
    Milton AH; Rahman H; Smith W; Shrestha R; Dear K
    J Water Health; 2006 Dec; 4(4):431-6. PubMed ID: 17176814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Weibull-PBPK model for assessing risk of arsenic-induced skin lesions in children.
    Liao CM; Lin TL; Chen SC
    Sci Total Environ; 2008 Mar; 392(2-3):203-17. PubMed ID: 18207220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic drinking water regulations in developing countries with extensive exposure.
    Smith AH; Smith MM
    Toxicology; 2004 May; 198(1-3):39-44. PubMed ID: 15138028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk characterization and exposure assessment in arseniasis-endemic areas of Taiwan.
    Ling MP; Liao CM
    Environ Int; 2007 Jan; 33(1):98-107. PubMed ID: 17014909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh.
    Rahman A; Vahter M; Ekström EC; Rahman M; Golam Mustafa AH; Wahed MA; Yunus M; Persson LA
    Am J Epidemiol; 2007 Jun; 165(12):1389-96. PubMed ID: 17351293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
    Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of background inorganic arsenic exposures to provide perspective on risk assessment results.
    Tsuji JS; Yost LJ; Barraj LM; Scrafford CG; Mink PJ
    Regul Toxicol Pharmacol; 2007 Jun; 48(1):59-68. PubMed ID: 17346867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.